144 ·Filed Jun 9, 2026
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral
The pre-planned 10b5-1 sale reduces signaling concerns, but continued insider selling warrants monitoring for potential overhang. The strong analyst consensus (93% bullish) and historical performance may offset bearish sentiment.
Final — all horizons settled through T+60d ⚠ clustered
AXSM ▼ -15.42% at T+60d
NEUTRAL call ✗ call lost -15.42% · α vs SPY -22.00% · entry $246.34 → $208.35
T+1d
+3.02%
call +3.02% · α +1.32%
$253.77
settled 4mo ago
T+5d
+2.26%
call +2.26% · α -1.17%
$251.91
settled 4mo ago
T+20d
+1.06%
call +1.06% · α -2.56%
$248.95
settled 3mo ago
T+60d
-15.42%
call -15.42% · α -22.00%
$208.35
settled 29d ago
Price Chart
Loading chart...
Executive Summary
CEO Herriot Tabuteau files Form 144 to sell 49,670 shares of Axsome Therapeutics (~$12.2M) under a 10b5-1 plan dated 3/10/2026. The sale is pre-planned but adds to recent insider selling activity.
Key Facts
- CEO Herriot Tabuteau files to sell 49,670 shares (~$12.2M) under a 10b5-1 plan.
- The 10b5-1 plan was established on 3/10/2026, indicating pre-planned sale.
- Recent insider selling (30d) totals $19.9M, with this filing adding to the trend.
Financial Impact
CEO selling ~$12.2M in shares; secondary market sale, no dilution.
Risk Factors
- Insider selling pattern could indicate management caution.
- Potential overhang from planned sales.
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
93% bullish (27 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001958244-26-000358 |
| Document: 0001958244-26-000358-index.html | 0001958244-26-000358 |
| Document: 0001958244-26-000358.txt | 0001958244-26-000358 |
23 reports for AXSM
83% Hit rate best @ T+60▲ +14.74%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 11, 2026 7w ago | Institutional Cluster | $214.66 $211.12 | ▼ −1.65% | ▲ +0.25% | $179.25 (−16.50%) |
Aug 10, 2026 7w ago | 8-K | $220.89 $207.82 | ▼ −5.92% | ▼ −5.00% | $179.25 (−18.85%) |
Aug 10, 2026 7w ago | Press Release | $220.89 $207.82 | ▼ −5.92% | ▼ −5.00% | $179.25 (−18.85%) |
Jul 15, 2026 11w ago | Press Release | $237.53 $214.66 | ▼ −9.63% | ▼ −11.97% | $179.25 (−24.54%) |
Jul 9, 2026 12w ago | Court Ruling | $248.95 $210.13 | ▼ −15.59% | ▼ −17.84% | $179.25 (−28.00%) |
Jul 7, 2026 12w ago | Press Release | $249.76 $211.04 | ▼ −15.50% | ▼ −16.84% | $179.25 (−28.23%) |
Jul 1, 2026 13w ago | 144 | $244.31 $234.64 | ▼ −3.96% | ▼ −3.54% | $179.25 (−26.63%) |
Jun 15, 2026 15w ago | Press Release | $253.40 $228.28 | ▼ −9.91% | ▼ −9.16% | $179.25 (−29.26%) |
Jun 12, 2026 16w ago | Insider Cluster | $255.17 $233.80 | ▼ −8.37% | ▼ −10.15% | $179.25 (−29.75%) |
Jun 11, 2026 16w ago | 144 | $255.17 $233.80 | ▼ −8.37% | ▼ −10.15% | $179.25 (−29.75%) |
Showing 10 of 23
US Market Status
Market Closed — Opens Mon (64h 59m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access